1.
Toi Y, Kimura Y, Domeki Y, Kawana S, Aiba T, Ono H, Asou M, Tsurumi K, Suzuki K, Shimizu H, Sugisaka J, Saito R, Terayama K, Kawashima Y, Nakamura A, Yamanda S, Honda Y, Sugawara S. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study: BSA and nintedanib reduction/discontinuation. Sarcoidosis VDLD [Internet]. 2019 Mar. 11 [cited 2021 Sep. 28];36(1):74-8. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/7383